Development of novel therapeutic procedures for obesity and obesity-associated diseases possibly could be achieved through an integral insight into leptin, resistin and visfatin, as well as insight into other adipokine functions and their links to inflammation. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.